Moreover, in MCF-7 human breast adenocarcinoma cells, the CD44-1 peptide had the strongest binding affinity for the HLA-A2 molecule, and CD44-1 peptide stimulated DC-CTLs exhibited the most efficient cytotoxic activity against CD44+ MCF-7 cells (Fig 1C). Here, CD44 is linked to breast adenocarcinoma.